Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | OTLK Outlook Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $0.63 +0.8% | $15.35 +3.1% |
| StockIQ Score | 41D Weak Risk: High | 38F Weak Risk: High |
| Technical | 23F | 24F |
| Fundamental | 30F | 35F |
| Growth | 63C+ | 50C- |
| Fair Value | 50C- | 38F |
| News | 68B- | 50C- |
| Quality | — | 50C- |
| Risk | 26F | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Outlook Therapeutics (OTLK) outperforms Ascentage Pharma (AAPG) in growth and valuation, scoring 63 versus 50 and 50 versus 38 respectively. However, AAPG has a slightly better investor score of 37 compared to OTLK’s 43, though both carry a "WEAK" rating. OTLK also leads in technical and fundamental scores, with 32 versus 18 and 30 versus 35.
